Fapon Biopharma Announces FDA Approval of IND for FP008, a First-in-Class Immunotherapy for Solid Tumors ...Middle East

DONGGUAN, China, Feb. 28, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for FP008, its...

Read More Details
Finally We wish PressBee provided you with enough information of ( Fapon Biopharma Announces FDA Approval of IND for FP008, a First-in-Class Immunotherapy for Solid Tumors )

Also on site :

• UK pauses trade negotiations with Israel and summons Israeli ambassador
• Jeff Bezos spanks bikini-clad Lauren Sanchez as she sunbathes on their $500M superyacht
• Woman Picks Up Dog From Groomer—Discovers They Gave Up Halfway Through